US
Us Congress House Bill HB1082

Us Congress 2025-2026 Regular Session

Us Congress House Bill HB1082

Introduced
2/6/25  
Refer
2/6/25  
Report Pass
4/29/25  

Caption

Shandra Eisenga Human Cell and Tissue Product Safety Act

Companion Bills

US HB340

Related The HCT/P Modernization Act of 2025This bill requires the Food and Drug Administration (FDA) to provide information to stakeholders and report on the regulation of human cell and tissue products, also referred to as human cells, tissues, or cellular or tissue-based products (HCT/Ps), which are articles containing or consisting of human cells or tissues that are intended for use in a human recipient.The bill requires the FDA to conduct workshops to educate stakeholders and facilitate discussion with them on advancing the science and regulation of human cell and tissue products. The FDA must establish a public docket to receive written comments on this topic, and submit to Congress a report with recommendations on regulating these products. Additionally, the bill requires the FDA to publish on its website educational materials about the Tissue Reference Group and best practices for obtaining a recommendation about products from them. Also, annually for three years, the FDA must publish on its website information on the inquiries submitted and average response times for the Tissue Reference Group, as well as the number of human cell and tissue manufacturers that have registered with the FDA and the number of inspections the FDA has conducted with respect to these manufacturers since 2019. (The Tissue Reference Group is a working group within the FDA that receives product-specific questions from, and provides recommendations for, stakeholders on the regulation of human cell and tissue products under the FDA’s rules.) 

Previously Filed As

US HB7188

Shandra Eisenga Human Cell and Tissue Product Safety Act

US SB3733

Shandra Eisenga Human Cell and Tissue Product Safety Act

US HB8251

The HCT/P Modernization Act of 2024

US HB398

Protecting Life and Integrity in Research Act of 2023 This bill restricts research that uses human fetal tissue from an induced abortion. Specifically, it prohibits the Department of Health and Human Services from conducting or supporting such research. Additionally, the bill applies requirements on the research of transplantation of fetal tissue for therapeutic purposes to research on fetal tissue in general. The bill also prohibits soliciting or acquiring a donation of human fetal tissue from an induced abortion, other than for purposes of an autopsy or burial.

US HB5605

Humanitarian Standards for Individuals in Customs and Border Protection Custody Act

US HB1628

CBD Product Safety and Standardization Act of 2023

US HB6109

PILLS Act Producing Incentives for Long-term production of Lifesaving Supply of Medicine Act

US HB9258

Disrupt Fentanyl Pill Production Act

US HB2811

Water Quality Certification and Energy Project Improvement Act of 2023 TAPP American Resources Act Transparency, Accountability, Permitting, and Production of American Resources Act Regulations from the Executive in Need of Scrutiny Act of 2023

US HB4304

ISLET Act Increase Support for Life-saving Endocrine Transplantation Act

Similar Bills

CA SB493

District agricultural associations: secretary-managers: compensation.

LA HB528

Reforms the organizational structure for the Department of Transportation and Development including its duties, powers, and responsibilities of officers and employees (EN INCREASE SD EX See Note)

MO HB2798

Modifies the "Missouri Family Trust Company Act"

CA AB1044

Elections: Secretary of State.

AR SB63

To Amend Arkansas Law Concerning Reports By The Secretaries Of Cabinet-level Departments On The State Of Their Departments.

CA AB1206

Voter registration database: Electronic Registration Information Center.

CA SB297

Elections: initiatives and referenda: withdrawal.

CA AB1004

Secretary of State: voter information Internet Web site.